A Prospective Comparative Study of the Toxicity Profile of 5-Flurouracil, Adriamycin, Cyclophosphamide Regime VS Adriamycin, Paclitaxel Regime in Patients with Locally Advanced Breast Carcinoma

INTRODUCTION: A 5-flurouracil, Adriamycin, Cyclophosphamide (FAC) and Adriamycin, Paclitaxel (AT) are two popular chemotherapeutic regimens for treatment of breast carcinoma. The most time tested and popular regimen is FAC. It is extensively studied for efficacy and toxicity. But data regarding toxi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Diagn Res
Autors principals: Shajahan, Jihana, Pillai, Pradeep Sadasivan, Jayakumar, Krishnan Nair Lalithamma
Format: Artigo
Idioma:Inglês
Publicat: JCDR Research and Publications (P) Limited 2015
Matèries:
Pharmacology Section
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717709/
https://ncbi.nlm.nih.gov/pubmed/26870703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2015/15939.6864
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars